Related Experiment Video

Updated: Oct 8, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

[Excessive growth and growth hormone deficiency after treatment for craniopharyngioma]

J P López Siguero1, E García García, M J Martínez-Aedo

  • 1Departamento de Pediatría, Hospital Materno-Infantil Carlos Haya, Málaga.

Anales Espanoles De Pediatria
|September 22, 2000
PubMed

Insights

Children with craniopharyngioma may experience normal growth despite hormone deficiency after tumor removal. Growth hormone therapy can effectively boost growth rates in these cases.

Area of Science:

  • Pediatric Endocrinology
  • Neuro-oncology
  • Growth Hormone Research

Background:

  • Craniopharyngioma is a brain tumor often affecting the pituitary gland.
  • Tumor removal can lead to panhypopituitarism, including growth hormone deficiency.
  • Altered growth patterns are observed in some children post-surgery.

Observation:

  • A 4-year-old girl with a suprasellar craniopharyngioma underwent tumor removal.
  • Post-surgery, she developed panhypopituitarism.
  • Initial rapid growth (8.4-10.6 cm/year) was followed by a decline to 1.2 cm/year.

Findings:

  • Despite documented growth hormone deficiency, the patient exhibited significant initial growth.
  • Growth hormone administration was initiated.
  • Therapy successfully increased her growth rate to 9.3 cm/year.

Implications:

  • This case highlights the complex interplay of factors influencing growth after craniopharyngioma treatment.
  • It suggests potential alternative growth pathways or compensatory mechanisms in some children.
  • Growth hormone therapy remains a crucial intervention for managing growth deficits in pediatric pituitary disorders.

More Related Videos

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery09:53

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery

Published on: July 5, 2021

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection02:22

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection

Published on: April 12, 2024

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...